Bactericidal Effect of 5-Mercapto-2-nitrobenzoic Acid-Coated Silver Nanoclusters against Multidrug-Resistant Neisseria gonorrhoeae

ACS Appl Mater Interfaces. 2020 Jun 24;12(25):27994-28003. doi: 10.1021/acsami.0c06163. Epub 2020 Jun 12.

Abstract

Neisseria gonorrhoeae is among the most multidrug-resistant bacteria in circulation today, and new treatments are urgently needed. In this work, we demonstrate the ability of 5-mercapto-2-nitrobenzoic acid-coated silver nanoclusters (MNBA-AgNCs) to kill strains of Neisseria gonorrhoeae. Using an in vitro bactericidal assay, MNBA-AgNCs had been found to show significantly higher anti-gonococcal bioactivity than the antibiotics ceftriaxone and azithromycin and silver nitrate. These nanoclusters were effective against both planktonic bacteria and a gonococcal infection of human cell cultures in vitro. Treatment of human cells in vitro with MNBA-AgNCs did not induce significant release of lactate dehydrogenase, suggesting minimal cytotoxicity to eukaryotic cells. Our results suggest that MNBA-AgNCs hold great potential for topical treatment of localized gonorrhoeae.

Keywords: Neisseria gonorrhoeae; antibacterial properties; azithromycin; ceftriaxone; human cells; nanoparticles; silver nanoclusters.

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Azithromycin / chemistry
  • Azithromycin / pharmacology
  • Ceftriaxone / chemistry
  • Ceftriaxone / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • L-Lactate Dehydrogenase / metabolism
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects*
  • Silver Nitrate / chemistry
  • Silver Nitrate / pharmacology

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone
  • Azithromycin
  • Silver Nitrate
  • L-Lactate Dehydrogenase